NextCell Pharma AB (STO:NXTCL)

NextCell Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is September - August.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 5, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Market Capitalization	120	93	124	218	499	247
Market Cap Growth	51.56%	-25.00%	-43.31%	-56.21%	101.94%	132.75%
Enterprise Value	103	72	61	111	348	241
Last Close Price	1.08	1.27	3.60	6.35	14.50	9.46
PS Ratio	11.73	8.23	8.87	35.05	111.90	59.25
PB Ratio	2.92	1.37	1.63	1.89	3.32	9.41
P/TBV Ratio	2.92	1.37	1.63	1.89	3.32	9.41
EV/Sales Ratio	10.10	6.39	4.34	17.86	78.06	57.91
Asset Turnover	0.18	0.13	0.13	0.04	0.05	0.15
Inventory Turnover	21.40	22.79	14.12	-	-	-
Quick Ratio	3.00	5.06	5.32	14.40	35.60	10.68
Current Ratio	4.57	6.15	6.67	15.40	37.02	11.97
Return on Equity (ROE)	-90.26%	-58.55%	-41.63%	-26.02%	-27.86%	-71.90%
Return on Assets (ROA)	-44.89%	-31.72%	-24.01%	-15.62%	-16.73%	-39.17%
Return on Capital (ROIC)	-57.75%	-37.65%	-26.80%	-16.48%	-17.60%	-45.00%
Earnings Yield	-33.11%	-45.20%	-32.17%	-15.83%	-4.93%	-7.16%
FCF Yield	-32.06%	-40.79%	-38.72%	-18.74%	-5.28%	-8.00%
Buyback Yield / Dilution	-103.17%	-18.72%	-	-13.05%	-53.09%	-60.47%

Updated May 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.